Jiangsu Recbio Technology HKEX:2179:
LIU YONG RESIGNED AS CHAIRMAN
Jiangsu Recbio Technology Says Liu Yong Resigned As Chair
Jiangsu Recbio Technology Co., Ltd. on 6ix
Earlier from Jiangsu Recbio Technology
Later from Jiangsu Recbio Technology
- Jiangsu Recbio Technology Says New Drug Application For REC610 Shingles Vaccine Accepted By NMPA
- 2026 Interim Report
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement receipt of phase III clinical trial summary report for novel adjuvanted recombinant shingles vaccine REC610
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Follow Jiangsu Recbio Technology into a list and get an email when it puts out news.
Follow Jiangsu Recbio Technology